Active Ingredient: SUCRALFATE
Proprietary Name: SUCRALFATE
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 1GM/10ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209356
Product Number: 001
Approval Date: Dec 2, 2019
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
